- $76.57bn
- $80.78bn
- $12.55bn
- 88
- 17
- 91
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,225 | 8,599 | 10,876 | 12,623 | 12,555 |
Cost of Revenue | |||||
Gross Profit | 2,616 | 2,664 | 3,402 | 4,028 | 4,084 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,621 | 6,961 | 8,771 | 10,037 | 9,990 |
Operating Profit | 1,605 | 1,638 | 2,105 | 2,586 | 2,565 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,496 | 1,527 | 1,989 | 2,467 | 2,455 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,164 | 1,213 | 1,580 | 1,917 | 1,946 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,155 | 1,203 | 1,591 | 1,902 | 1,928 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,155 | 1,203 | 1,591 | 1,902 | 1,928 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.963 | 0.986 | 1.3 | 1.55 | 1.57 |
Dividends per Share |